Pharmacokinetics and dose linearity of von Willebrand factor factor VIII concentrate (Humate-P®) in elective surgery in von Willebrand disease patients.

被引：0
|
作者：
DiPaola, J
Gill, J
Bernstein, J
Leissinger, C
Valentino, L
Friedman, C
Knaub, S
机构：
[1] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA
[2] Ctr Blood, Comprehens Ctr Bleeding Disorders, Milwaukee, WI USA
[3] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[4] Hemophilia Treatment Ctr, Las Vegas, NV USA
[5] Tulane Univ, Sch Med, Dept Hematol Oncol, New Orleans, LA 70118 USA
[6] Rush Presbyterian St Lukes Hemophilia Ctr, Chicago, IL USA
[7] ZLB Behring LLC, Clin Res & Dev, King Of Prussia, PA USA
[8] ZLB Behring GmbH, Clin Res & Dev, Marburg, Germany
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1792
引用
收藏
页码：509A / 510A
页数：2
相关论文
共 50 条
  • [1] Dose linearity of von Willebrand factor factor VIII concentrate in elective surgery in von Willebrand disease patients.
    Mannucci, PM
    Kyrle, PA
    Schulman, S
    Haertel, S
    Lethagen, S
    [J]. BLOOD, 2003, 102 (11) : 312A - 312A
  • [2] von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease
    Gill, J. C.
    Shapiro, A.
    Valentino, L. A.
    Bernstein, J.
    Friedman, C.
    Nichols, W. L.
    Manco-Johnson, M.
    [J]. HAEMOPHILIA, 2011, 17 (06) : 895 - 905
  • [3] Safety and efficacy of von Willebrand factor/factor VIII concentrate (Humate-P®) for prophylaxis of excessive bleeding during elective surgery in patients with von Willebrand disease.
    Bernstein, Jonathan
    Gill, Joan Cox
    Leissinger, Cindy A.
    Di Paola, Jorge
    Ragni, Margaret V.
    Shopnick, Rinah
    Valentino, Leonard A.
    Friedman, Carl
    Knaub, Sigurd
    [J]. BLOOD, 2006, 108 (11) : 98B - 98B
  • [4] Von Willebrand factor/factor VIII concentrate (Humate-P®) for surgical prophylaxis of excessive bleeding in patients with von Willebrand disease (VWD).
    Gill, JC
    DiPaola, J
    Bernstein, J
    Leissinger, CA
    Valentino, L
    Friedman, C
    Knaub, S
    [J]. BLOOD, 2005, 106 (11) : 509A - 509A
  • [5] Pharmacokinetic evaluation of Von Willebrand factor/factor VIII concentrate (Humate-P@) prior to elective surgery in patients with Von Willebrand disease.
    Di Paola, Jorge
    Gill, Joan
    Bemstein, Jonathan
    Leissinger, Cindy
    Ragni, Margaret
    Shopnik, Rinah
    Valentino, Leonard
    Friedman, Carl
    Knaub, Sigurd
    [J]. BLOOD, 2006, 108 (11) : 98B - 99B
  • [6] Human Plasma von Willebrand Factor/Factor VIII Complex (Haemate® P/Humate-P®)In von Willebrand Disease and Haemophilia A
    Natalie J. Carter
    Lesley J. Scott
    [J]. Drugs, 2007, 67 : 1513 - 1519
  • [7] Human plasma von Willebrand factor/factor VIII complex (Haemate® P/Humate-P®) -: In von Willebrand disease and haemophilia A
    Carter, Natalie J.
    Scott, Lesley J.
    [J]. DRUGS, 2007, 67 (10) : 1513 - 1519
  • [8] Efficacy and safety of the Factor VIII/von Willebrand factor concentrate, Haemate-P/Humate-P: Ristocetin cofactor unit dosing in patients with von Willebrand disease
    Lillicrap, D
    Poon, MC
    Walker, I
    Xie, F
    Schwartz, BA
    [J]. THROMBOSIS AND HAEMOSTASIS, 2002, 87 (02) : 224 - 230
  • [9] Human plasma von Willebrand factor/factor VIII complex (Haemate® P/Humate-P®) in von Willebrand disease and haemophilia A -: A viewpoint
    Berntorp, Eric
    [J]. DRUGS, 2007, 67 (10) : 1520 - 1520
  • [10] Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII/VWF concentrate (Humate-P®)
    Thompson, AR
    Gill, JC
    Ewenstein, BM
    Mueller-Velten, G
    Schwartz, BA
    [J]. HAEMOPHILIA, 2004, 10 (01) : 42 - 51
12345